Clinical trial

Evaluating the Impact of Ketamine Gargling on Post Intubation Sore Throat: A Randomized Controlled Trial.

Name
Ketamine for POST
Description
Tracheal intubation often causes trauma to the airway mucosa, leading to postoperative sore throat (POST), which has been reported to occur in 21-65% of cases. While considered a minor complication, POST can contribute to postoperative discomfort and patient dissatisfaction.
Trial arms
Trial start
2024-04-25
Estimated PCD
2024-08-15
Trial end
2024-09-20
Status
Not yet recruiting
Treatment
Gargle with ketamine
The patients asked to gargling with ketamine solution in the preoperative waiting area after explain the whole procedure and the goals of the study.
Arms:
the 1st group (K group)
Other names:
Placebo
Size
80
Primary endpoint
Sore throat
2, 6, 12, and 24 hrs. postoperatively
Eligibility criteria
Inclusion Criteria: * Adult patients from both sex and aged between 18 and 45 years. * All participants were scheduled for elective laparoscopic appendectomy or cholecystectomy under general anesthesia. * Classified as ASA (American Society of Anesthesiologists) I or II. * Intubation duration is less than 90 minutes. Exclusion Criteria: * Patients classified as ASA III or higher. * Patients exhibiting symptoms of sore throat prior to entering the operating room, or presenting with any respiratory illness or signs of respiratory infection. * Patients who smoke. * Patients with a history of allergy to drugs used in this study. * Patients who are addicted to steroid drugs (inhaled or oral). * Patients with predicted difficult airway and intubation, indicated by a Mallampati score of II or higher. * Obese patients with a BMI exceeding 35. * Patients with neurological diseases.
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 80, 'type': 'ESTIMATED'}}
Updated at
2024-04-16

1 organization

1 product

1 indication

Product
Ketamine